特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
916067

世界の抗結核薬市場:規模、情勢、および予測(2019年~2025年)

Global Anti-tuberculosis Therapeutics Market Size, Status and Forecast 2019-2025

出版日: | 発行: QYResearch | ページ情報: 英文 97 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.58円
世界の抗結核薬市場:規模、情勢、および予測(2019年~2025年)
出版日: 2019年11月11日
発行: QYResearch
ページ情報: 英文 97 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界の抗結核薬市場について調査し、市場動向や予測、成長要因および課題、タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査範囲
  • 主要市場セグメント
  • 対象となる企業
  • 市場分析:タイプ別
    • 市場規模成長率
    • イソニアジド
    • リファンピン
    • エタンブトール
    • ピラジナミド
    • その他
  • 市場分析:用途別
    • 市場シェア
    • 病院・診療所
    • 政府機関
    • 非営利団体
    • その他
  • 調査の目的
  • 考慮される年

第2章 世界の成長動向

  • 市場規模
  • 地域別の成長動向
    • 市場規模
    • 市場シェア
  • 産業の動向
    • 市場の主な動向
    • 市場成長要因
    • 市場の課題
    • ポーターのファイブフォース分析

第3章 市場シェア:主要企業別

  • 市場規模
    • 収益
    • 市場シェア
    • 市場集中率(CR5およびHHI)
  • 主要企業の本社および提供エリア
  • 主要企業の製品/ソリューション/サービス
  • 市場参入日
  • 合併・買収、拡張計画

第4章 市場分析:タイプ・用途別

  • タイプ別の市場規模
  • 用途別の市場規模

第5章 北米

  • 市場規模
  • 主要企業
  • タイプ別
  • 用途別

第6章 欧州

第7章 中国

第8章 日本

第9章 東南アジア

第10章 インド

第11章 中南米

第12章 企業プロファイル

  • Lupin
  • Macleods Pharmaceuticals
  • 大塚製薬株式会社
  • Johnson & Johnson
  • Pfizer
  • Novartis
  • Abbott
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • GlaxoSmithKline
  • Merck
  • Sanofi

第13章 市場予測

  • 製品別
  • 用途別
  • 地域別の市場規模予測
  • 北米
  • 欧州
  • 中国
  • 日本
  • 東南アジア
  • インド
  • 中南米

第14章 アナリストの見解・結論

第15章 付録

  • 調査方法
    • 調査方法/調査アプローチ
    • 情報源
  • 免責事項
  • 著者の詳細
図表

List of Tables and Figures

  • Table Anti-tuberculosis Therapeutics Key Market Segments
  • Table Key Players Anti-tuberculosis Therapeutics Covered
  • Table Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
  • Figuer Isoniazid Figures
  • Table Key Players of Isoniazid
  • Figuer Rifampin Figures
  • Table Key Players of Rifampin
  • Figuer Ethambutol Figures
  • Table Key Players of Ethambutol
  • Figuer Pyrazinamide Figures
  • Table Key Players of Pyrazinamide
  • Figuer Otherr Figures
  • Table Key Players of Otherr
  • Table Global Anti-tuberculosis Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
  • Figure Global Anti-tuberculosis Therapeutics Market Share by Application in 2018 & 2025
  • Figure Hospitals and Clinics Case Studies
  • Figure Government Agencies Case Studies
  • Figure Non-Profit Organizations Case Studies
  • Figure Others Case Studies
  • Figure Anti-tuberculosis Therapeutics Report Years Considered
  • Figure Global Anti-tuberculosis Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Anti-tuberculosis Therapeutics Market Size by Regions 2019-2025 (Million US$)
  • Table Global Anti-tuberculosis Therapeutics Market Size by Regions 2019-2025 (Million US$)
  • Table Global Anti-tuberculosis Therapeutics Market Share by Regions 2014-2019
  • Figure Global Anti-tuberculosis Therapeutics Market Share by Regions 2014-2019
  • Figure Global Anti-tuberculosis Therapeutics Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Key Drivers: Impact Analysis (2019-2025)
  • Table Key Challenges
  • Figure PORTER'S FIVE FORCES ANALYSIS
  • Table Global Anti-tuberculosis Therapeutics Revenue by by Players (2014-2019) (Million US$)
  • Table Global Anti-tuberculosis Therapeutics Market Share by by Players (2014-2019)
  • Figure Global Anti-tuberculosis Therapeutics Market Share by by Players in 2018
  • Table Global Anti-tuberculosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Anti-tuberculosis Therapeutics Product/Solution/Service
  • Table Date of Enter into Anti-tuberculosis Therapeutics Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Anti-tuberculosis Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Global Anti-tuberculosis Therapeutics Market Size Share by Type (2014-2019)
  • Figure Global Anti-tuberculosis Therapeutics Market Size Market Share by Type (2014-2019)
  • Table Global Anti-tuberculosis Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Global Anti-tuberculosis Therapeutics Market Size Share by Application (2014-2019)
  • Figure Global Anti-tuberculosis Therapeutics Market Size Market Share by Application (2014-2019)
  • Figure Global Anti-tuberculosis Therapeutics Revenue Market Share by Application in 2018
  • Figure North America Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table North America Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table North America Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table North America Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table North America Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table North America Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table North America Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Figure Europe Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table Europe Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Europe Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table Europe Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Europe Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Figure China Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table China Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table China Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table China Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table China Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table China Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table China Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Figure Japan Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table Japan Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Japan Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table Japan Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Japan Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Figure Southeast Asia Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table Southeast Asia Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Southeast Asia Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table Southeast Asia Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Southeast Asia Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Figure India Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table India Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table India Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table India Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table India Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table India Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table India Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Figure Central & South America Anti-tuberculosis Therapeutics Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Anti-tuberculosis Therapeutics Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Anti-tuberculosis Therapeutics Market Share (2018-2019)
  • Table Central & South America Anti-tuberculosis Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Central & South America Anti-tuberculosis Therapeutics Market Share by Type 2014-2019
  • Table Central & South America Anti-tuberculosis Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Central & South America Anti-tuberculosis Therapeutics Market Share by Application 2014-2019
  • Table Lupin Company Details
  • Table Lupin Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Lupin Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Lupin Recent Development
  • Table Macleods Pharmaceuticals Company Details
  • Table Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Macleods Pharmaceuticals Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Macleods Pharmaceuticals Recent Development
  • Table Otsuka Pharmaceutical Company Details
  • Table Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Otsuka Pharmaceutical Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Otsuka Pharmaceutical Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Johnson & Johnson Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Pfizer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Pfizer Recent Development
  • Table Novartis Company Details
  • Table Novartis Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Novartis Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Novartis Recent Development
  • Table Abbott Company Details
  • Table Abbott Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Abbott Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Abbott Recent Development
  • Table AstraZeneca Company Details
  • Table AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure AstraZeneca Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table AstraZeneca Recent Development
  • Table Bayer Company Details
  • Table Bayer Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Bayer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Bayer Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business 2014-2019 (Million US$)
  • Figure Eli Lilly Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2014-2019)
  • Table Eli Lilly Recent Development
  • Table GlaxoSmithKline Company Details
  • Table Merck Company Details
  • Table Sanofi Company Details
  • Table Global Anti-tuberculosis Therapeutics Market Size by Regions (Million US$) 2019-2025
  • Figure Global Anti-tuberculosis Therapeutics Market Size Share by Regions (2019-2025)
  • Figure Global Anti-tuberculosis Therapeutics Market Size Share by Regions in 2025
  • Figure North America Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure China Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure India Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Anti-tuberculosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Table Global Anti-tuberculosis Therapeutics Market Size by Product (2019-2025) (Million US$)
  • Figure Global Anti-tuberculosis Therapeutics Market Size by Product (2019-2025)
  • Figure Global Anti-tuberculosis Therapeutics Market Size by Product in 2025
  • Table Global Anti-tuberculosis Therapeutics Market Size by Application (2019-2025) (Million US$)
  • Figure Global Anti-tuberculosis Therapeutics Market Size by Application (2019-2025)
  • Figure Global Anti-tuberculosis Therapeutics Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.

In 2018, the global Anti-tuberculosis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Anti-tuberculosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-tuberculosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

  • Lupin
  • Macleods Pharmaceuticals
  • Otsuka Pharmaceutical
  • Johnson & Johnson
  • Pfizer
  • Novartis
  • Abbott
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • GlaxoSmithKline
  • Merck
  • Sanofi

Market segment by Type, the product can be split into

  • Isoniazid
  • Rifampin
  • Ethambutol
  • Pyrazinamide
  • Otherr

Market segment by Application, split into

  • Hospitals and Clinics
  • Government Agencies
  • Non-Profit Organizations
  • Others

Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Anti-tuberculosis Therapeutics status, future forecast, growth opportunity, key market and key players.
  • To present the Anti-tuberculosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anti-tuberculosis Therapeutics are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Isoniazid
    • 1.4.3 Rifampin
    • 1.4.4 Ethambutol
    • 1.4.5 Pyrazinamide
    • 1.4.6 Otherr
  • 1.5 Market by Application
    • 1.5.1 Global Anti-tuberculosis Therapeutics Market Share by Application (2019-2025)
    • 1.5.2 Hospitals and Clinics
    • 1.5.3 Government Agencies
    • 1.5.4 Non-Profit Organizations
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Anti-tuberculosis Therapeutics Market Size
  • 2.2 Anti-tuberculosis Therapeutics Growth Trends by Regions
    • 2.2.1 Anti-tuberculosis Therapeutics Market Size by Regions (2019-2025)
    • 2.2.2 Anti-tuberculosis Therapeutics Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter's Five Forces Analysis

3 Market Share by Key Players

  • 3.1 Anti-tuberculosis Therapeutics Market Size by by Players
    • 3.1.1 Global Anti-tuberculosis Therapeutics Revenue by by Players (2014-2019)
    • 3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by by Players (2014-2019)
    • 3.1.3 Global Anti-tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2 Anti-tuberculosis Therapeutics Key Players Head office and Area Served
  • 3.3 Key Players Anti-tuberculosis Therapeutics Product/Solution/Service
  • 3.4 Date of Enter into Anti-tuberculosis Therapeutics Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Anti-tuberculosis Therapeutics Market Size by Type (2014-2019)
  • 4.2 Global Anti-tuberculosis Therapeutics Market Size by Application (2014-2019)

5 North America

  • 5.1 North America Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 5.2 Anti-tuberculosis Therapeutics Key Players in North America
  • 5.3 North America Anti-tuberculosis Therapeutics Market Size by Type
  • 5.4 North America Anti-tuberculosis Therapeutics Market Size by Application

6 Europe

  • 6.1 Europe Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 6.2 Anti-tuberculosis Therapeutics Key Players in Europe
  • 6.3 Europe Anti-tuberculosis Therapeutics Market Size by Type
  • 6.4 Europe Anti-tuberculosis Therapeutics Market Size by Application

7 China

  • 7.1 China Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 7.2 Anti-tuberculosis Therapeutics Key Players in China
  • 7.3 China Anti-tuberculosis Therapeutics Market Size by Type
  • 7.4 China Anti-tuberculosis Therapeutics Market Size by Application

8 Japan

  • 8.1 Japan Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 8.2 Anti-tuberculosis Therapeutics Key Players in Japan
  • 8.3 Japan Anti-tuberculosis Therapeutics Market Size by Type
  • 8.4 Japan Anti-tuberculosis Therapeutics Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 9.2 Anti-tuberculosis Therapeutics Key Players in Southeast Asia
  • 9.3 Southeast Asia Anti-tuberculosis Therapeutics Market Size by Type
  • 9.4 Southeast Asia Anti-tuberculosis Therapeutics Market Size by Application

10 India

  • 10.1 India Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 10.2 Anti-tuberculosis Therapeutics Key Players in India
  • 10.3 India Anti-tuberculosis Therapeutics Market Size by Type
  • 10.4 India Anti-tuberculosis Therapeutics Market Size by Application

11 Central & South America

  • 11.1 Central & South America Anti-tuberculosis Therapeutics Market Size (2014-2019)
  • 11.2 Anti-tuberculosis Therapeutics Key Players in Central & South America
  • 11.3 Central & South America Anti-tuberculosis Therapeutics Market Size by Type
  • 11.4 Central & South America Anti-tuberculosis Therapeutics Market Size by Application

12 International Players Profiles

  • 12.1 Lupin
    • 12.1.1 Lupin Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Anti-tuberculosis Therapeutics Introduction
    • 12.1.4 Lupin Revenue in Anti-tuberculosis Therapeutics Business (2014-2019))
    • 12.1.5 Lupin Recent Development
  • 12.2 Macleods Pharmaceuticals
    • 12.2.1 Macleods Pharmaceuticals Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Anti-tuberculosis Therapeutics Introduction
    • 12.2.4 Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.2.5 Macleods Pharmaceuticals Recent Development
  • 12.3 Otsuka Pharmaceutical
    • 12.3.1 Otsuka Pharmaceutical Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Anti-tuberculosis Therapeutics Introduction
    • 12.3.4 Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.3.5 Otsuka Pharmaceutical Recent Development
  • 12.4 Johnson & Johnson
    • 12.4.1 Johnson & Johnson Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Anti-tuberculosis Therapeutics Introduction
    • 12.4.4 Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.4.5 Johnson & Johnson Recent Development
  • 12.5 Pfizer
    • 12.5.1 Pfizer Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Anti-tuberculosis Therapeutics Introduction
    • 12.5.4 Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.5.5 Pfizer Recent Development
  • 12.6 Novartis
    • 12.6.1 Novartis Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Anti-tuberculosis Therapeutics Introduction
    • 12.6.4 Novartis Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.6.5 Novartis Recent Development
  • 12.7 Abbott
    • 12.7.1 Abbott Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Anti-tuberculosis Therapeutics Introduction
    • 12.7.4 Abbott Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.7.5 Abbott Recent Development
  • 12.8 AstraZeneca
    • 12.8.1 AstraZeneca Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Anti-tuberculosis Therapeutics Introduction
    • 12.8.4 AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.8.5 AstraZeneca Recent Development
  • 12.9 Bayer
    • 12.9.1 Bayer Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Anti-tuberculosis Therapeutics Introduction
    • 12.9.4 Bayer Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.9.5 Bayer Recent Development
  • 12.10 Eli Lilly
    • 12.10.1 Eli Lilly Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Anti-tuberculosis Therapeutics Introduction
    • 12.10.4 Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2014-2019)
    • 12.10.5 Eli Lilly Recent Development
  • 12.11 GlaxoSmithKline
  • 12.12 Merck
  • 12.13 Sanofi

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Product (2019-2025)
  • 13.2 Market Size Forecast by Application (2019-2025)
  • 13.3 Market Size Forecast by Regions
  • 13.4 North America
  • 13.5 Europe
  • 13.6 China
  • 13.7 Japan
  • 13.8 Southeast Asia
  • 13.9 India
  • 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.